Artiva Biotherapeutics, Inc.
USD9.76
+0.18 (+1.88%)
CEO
Fred Aslan
IPO Date
2024-07-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.87
Prev. Close
$9.58
Day Low
$9.55
Day High
$9.95
52W Low
$1.50
52W High
$14.53
Market Cap
$0.24B
Volume
0.24M
| -4.2 |
| 31 Dec 2023 | FY | 100.0% | -82.7% | 17.1% | -26.3% | -0.10 | 6.53 | -10.1 |
| 31 Dec 2022 | FY | 100.0% | -1184.1% | 41.5% | -43.9% | -0.14 | 4.08 | -3.6 |
| 31 Dec 2021 | FY | 100.0% | -3587.7% | 80.8% | -42.3% | -0.02 | 8.41 | -2.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 83.4% | -61.5% | -0.10 | 4.53 | -11.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 0.0% | 0.0% | -1.97 | 2.08 | 0.0 |
| -1.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.7% | -14.5% | 0.09 | 11.65 | -0.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.3% | -12.5% | 0.09 | 13.84 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -12.0% | -10.6% | 0.08 | 13.93 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -4.9% | -4.4% | 0.08 | 15.39 | -6.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.7% | -7.7% | 0.07 | 11.33 | -5.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 9.3% | -23.5% | -0.08 | 4.59 | -3.9 |
| 31 Mar 2024 | Q1 | 100.0% | -5562.9% | 8.0% | -15.5% | -0.09 | 6.35 | -3.8 |
| 31 Dec 2023 | Q4 | 100.0% | -510.6% | 7.4% | -11.4% | -0.10 | 6.53 | -5.1 |